| Literature DB >> 29223768 |
Mathilde Antoniades1, Tabea Schoeler2, Joaquim Radua3, Isabel Valli2, Paul Allen4, Matthew J Kempton2, Philip McGuire2.
Abstract
This meta-analysis summarizes research examining whether deficits in verbal learning are related to bilateral hippocampal volume reductions in patients with or at risk for schizophrenia and in healthy controls. 17 studies with 755 patients with schizophrenia (SCZ), 232 Genetic High Risk (GHR) subjects and 914 healthy controls (HC) were included. Pooled correlation coefficients were calculated between hemisphere (left, right or total) and type of recall (immediate or delayed) for each diagnostic group individually (SCZ, GHR and HC). In SCZ, left and right hippocampal volume positively correlated with immediate (r=0.256, 0.230) and delayed (r=0.132, 0.231) verbal recall. There was also a correlation between total hippocampal volume and delayed recall (r=0.233). None of these correlations were significant in healthy controls. There was however, a positive correlation between left hippocampal volume and immediate recall in the GHR group (r=0.356). The results suggest that hippocampal volume affects immediate and delayed verbal learning capacity in schizophrenia and provides further evidence of hippocampal dysfunction in the pathophysiology of schizophrenia.Entities:
Keywords: Cognition; MRI; Medial temporal lobe; Memory; Schizophrenia; Volume
Mesh:
Year: 2017 PMID: 29223768 PMCID: PMC5818020 DOI: 10.1016/j.neubiorev.2017.12.001
Source DB: PubMed Journal: Neurosci Biobehav Rev ISSN: 0149-7634 Impact factor: 8.989
Fig. 1Flow chart of the screening and selection process.
Description of the demographic, cognitive and neuroimaging measures and covariates of the samples included in the meta-analysis.
| Study | Task | Region | Covariates | Stage | n | Age (mean) | Males (%) | AP Med (%) | n | Age (mean) | Males (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immediate recall | Schizophrenia or GHR | Healthy Controls | |||||||||
| WMS-R LM I | L/R Hipp, Ant & Post | Edu | SCZ | 25 old | 55.92 | 76 | 88 | 21 | 53.67 | 57.1 | |
| 23 young | 32.78 | 60.9 | 100 | ||||||||
| HVLT total immediate | L/R Hipp | Age, sex, Edu, PANSS total | FEP | 51 | 22.5 | 64.7 | 0 | 41 | 22.8 | 58.5 | |
| WMS-R LM I | L/R Sub | None | GHR | 46 | 25 | 30.4 | 0 | 30 | 24 | 43.3 | |
| WMS-R LM I | L/R Hipp | None | SCZ | 19 | 34.3 | 73.68 | 100* | 20 | 27.4 | 90 | |
| WMS-R LM I | L/R Ant & Post | ICV | SCZ | 24 | 40.09 | 83.33 | 100 | 24 | 41.74 | 66.67 | |
| WMS-R LM I | L/R Hipp | None | SCZ | 21 | 31 | 66.67 | 100 | 21 | 29 | 61.9 | |
| WMS-R LM I | L/R Hipp | Sex, group, sex*group, Hand, Eth, parental Edu, IQ | GHR | 28 simplex | 41.9 | 35.7 | 0 | 48 | 40.1 | 56.3 | |
| 17 multiplex | 38.9 | 41.2 | |||||||||
| Delayed recall | Schizophrenia or GHR | Healthy Controls | |||||||||
| WMS-R LM II | L/R Hipp, Ant & Post | Edu | SCZ | 25 old | 55.92 | 76 | 88 | 21 | 53.67 | 57.1 | |
| 23 young | 32.78 | 60.9 | 100 | ||||||||
| CVLT delayed free recall | Total Sub | None | SCZ | 177 | 31.6 | 61 | 84.7 | 261 | 36 | 52 | |
| RAVLT trial 7 | L/R Hipp | None | FEP | 90 | 83 | ||||||
| HVLT total | L/R Sub | None | GHR | 46 | 25 | 30.4 | 0 | 30 | 24 | 43.3 | |
| WMS-R LM I, LM II & CVLT composite | L Hipp | Sex | SCZ | 36 | 22.5 | 84.6 | 84.6 | 46 | 21.1 | 56.52 | |
| GHR | 31 | 22.1 | 45.5 | 0 | 49 | 20.4 | 28 | ||||
| WMS-R LM II | L/R Hipp | None | SCZ | 19 | 34.3 | 73.68 | 100* | 20 | 27.4 | 90 | |
| WMS-R LM II | L/R Ant & Post | ICV | SCZ | 24 | 40.09 | 83.33 | 100 | 24 | 41.74 | 66.67 | |
| WMS-R LM II | L/R and total Hipp | None | SCZ | 21 | 31 | 66.67 | 100 | 21 | 29 | 61.9 | |
| RAVLT delayed | L Ant | None | SCZ | 28 | 27.7 | 75 | 100 | 33 | 28.09 | 63.64 | |
| WMS-R LM II | L/R Hipp | MD | SCZ | 24 | 40.3 | 100 | 100 | 31 | 40.6 | 100 | |
| WMS-R LM II | L Hipp | Age, gender, group | SCZ | 56 | 32.8 | 69.7 | 100 | 55 | 38.8 | 49.1 | |
| GHR | 90 | 50.2 | 37.8 | 0 | |||||||
| WMS-R LM II | L/R Hipp | Sex, group, sex*group, Hand, Eth, parental Edu, IQ | GHR | 28 simplex | 41.9 | 35.7 | 0 | 48 | 40.1 | 56.3 | |
| 17 multiplex | 38.9 | 41.2 | |||||||||
| WAIS, WMS-R LM I, LM II, Buschke | L/R Hipp | ICV, age | SCZ | 62 | 38.8 | 100 | 100 | 27 | 35.7 | 100 | |
| O’driscoll et al. (2001) | WMS-R LM II | L/R and total Am/Hipp | None | GHR | 20 | 36.2 | 45 | 0 | 14 | 35.4 | 36 |
| WMS-R LM I, LM II & CVLT (1–5) | Total Hipp | None | SCZ | 100 | 29.2 | 58 | 61 | 110 | 26.1 | 51 | |
| LM1 &2, VR, WAIS, COWAT, WCST | L/R Hipp | None | SCZ | 20 | 64.4 | 60 | 100 | 24 | 72.67 | 79 | |
WMS-R: Wechsler memory scale-revised, LM I: logical memory 1 (i.e. immediate recall), LM II: logical memory 2 (i.e. delayed recall), SCZ: schizophrenia; AP Med: antipsychotic medication, GHR: genetic high risk; RAVLT: Rey Auditory Verbal Learning Task, HVLT: Hopkins verbal learning task, ICV: intracranial volume, L/R: left/right, Sub: subiculum, Hipp: hippocampus, Am: amygdala, Ant: anterior, Post: posterior, Edu: education, Eth: ethnicity, MD: medication dosage, Hand: handedness, * denotes that all patients were medicated but the study does not specify the type of medication.
Fig. 2Graph showing that verbal learning in patients with schizophrenia and their relatives is 55–90% that of healthy controls whereas hippocampal volume is 75–105% that of controls. Memory scores and hippocampal volumes of healthy controls were all set to 100% and are not shown on the graph.
Comparison of MetaNSUE findings using combined, simple and partial correlation coefficients in patients with schizophrenia and healthy controls.
| Analysis (group, hemisphere, type of recall) | Simple and partial correlations combined | Simple correlations only | Partial correlations only | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of independent studies (number of correlations) | Number of NSUEs | Total* number of subjects | Meta-analysis result: Correlation coefficient ( | 95% CI | Number of independent studies (number of correlations) | Number of NSUEs | Total* number of subjects | Meta-analysis result: Correlation coefficient ( | 95% CI | Number of independent studies (number of correlations) | Number of NSUEs | Total* number of subjects | Meta-analysis result: Correlation coefficient ( | 95% CI | |
| SCZ left immediate | 5 (8) | 0 | 162 | 0.256 (0.0029) | 0.089 to 0.409 | 3 (4) | 0 | 63 | 0.146 (0.24) | -0.095 to 0.371 | 3 (6) | 0 | 123 | 0.242 (0.097) | −0.045 to 0.493 |
| SCZ left delayed | 11 (15) | 0 | 431 | 0.131 (0.0038) | 0.042 to 0.218 | 7 (8) | 0 | 229 | 0.179 (0.0304) | 0.017 to 0.332 | 6 (10) | 0 | 250 | 0.153 (0.0464) | 0.002 to 0.297 |
| SCZ right immediate | 5 (8) | 0 | 162 | 0.230 (0.001) | 0.094 to 0.358 | 3 (4) | 0 | 63 | 0.174 (0.15) | −0.066 to 0.396 | 3 (6) | 0 | 123 | 0.128 (0.37) | −0.150 to 0.387 |
| SCZ right delayed | 8 (12) | 0 | 311 | 0.234 (<0.0001) | 0.135 to 0.329 | 6 (7) | 0 | 201 | 0.256 (0.0013) | 0.102 to 0.398 | 4 (8) | 0 | 158 | 0.227 (0.093) | −0.038 to 0.462 |
| HC left immediate | 7 (10) | 1 | 204 | 0.019 (0.87) | −0.207 to 0.243 | 4 (5) | 0 | 95 | −0.122 (0.43) | −0.402 to 0.178 | 4 (7) | 1 | 133 | 0.248 (0.0073) | 0.068 to 0.412 |
| HC left delayed | 15 (19) | 7 | 519 | 0.065 (0.26) | −0.049 to 0.177 | 8 (9) | 2 | 243 | 0.103 (0.24) | −0.068 to 0.267 | 8 (12) | 5 | 302 | 0.075 (0.32) | −0.072 to 0.219 |
| HC right immediate | 7 (10) | 1 | 204 | 0.063 (0.57) | −0.152 to 0.272 | 4 (5) | 0 | 95 | −0.081 (0.62) | −0.379 to 0.233 | 4 (7) | 1 | 133 | 0.297 (0.0007) | 0.128 to 0.449 |
| HC right delayed | 11 (15) | 4 | 336 | 0.123 (0.0699) | −0.01 to 0.251 | 7 (8) | 1 | 210 | 0.095 (0.32) | −0.093 to 0.277 | 5 (9) | 3 | 150 | 0.207 (0.0235) | 0.028 to 0.372 |
*Total only includes the number of subjects from repeated measures once, NSUE: non-significant unreported effect, SCZ: schizophrenia, HC: healthy control, CI: confidence interval.